ATE408412T1 - Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration - Google Patents
Verwendung von cannabidiol zur hemmung von gehirntumorzellmigrationInfo
- Publication number
- ATE408412T1 ATE408412T1 AT05788521T AT05788521T ATE408412T1 AT E408412 T1 ATE408412 T1 AT E408412T1 AT 05788521 T AT05788521 T AT 05788521T AT 05788521 T AT05788521 T AT 05788521T AT E408412 T1 ATE408412 T1 AT E408412T1
- Authority
- AT
- Austria
- Prior art keywords
- cell migration
- cannabidiol
- tumor cell
- brain tumor
- inhibit brain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0421900A GB2418612A (en) | 2004-10-01 | 2004-10-01 | Inhibition of tumour cell migration with cannabinoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408412T1 true ATE408412T1 (de) | 2008-10-15 |
Family
ID=33427951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05788521T ATE408412T1 (de) | 2004-10-01 | 2005-09-30 | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20080262099A1 (de) |
| EP (1) | EP1802274B1 (de) |
| JP (5) | JP2008514687A (de) |
| AT (1) | ATE408412T1 (de) |
| CA (1) | CA2582289C (de) |
| DE (1) | DE602005009852D1 (de) |
| DK (1) | DK1802274T3 (de) |
| ES (1) | ES2313414T3 (de) |
| GB (1) | GB2418612A (de) |
| WO (1) | WO2006037981A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2448535A (en) * | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
| US9084771B2 (en) * | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
| GB2450493A (en) * | 2007-06-25 | 2008-12-31 | Gw Pharma Ltd | Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors |
| ATE493977T1 (de) * | 2007-10-02 | 2011-01-15 | Vivacell Biotechnology Espana S L | Zusammensetzung mit nicht-psychotropen cannabinoiden zur behandlung von entzündungserkrankungen |
| GB0808668D0 (en) * | 2008-05-13 | 2008-06-18 | Univ Aberdeen | Materials and methods relating to a G-protein coupled receptor |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2478074B (en) * | 2008-06-04 | 2012-12-26 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2475183B (en) * | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| KR20120111125A (ko) * | 2011-03-31 | 2012-10-10 | 주식회사한국전통의학연구소 | 마자인 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품 |
| GB2494461A (en) * | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
| GB201117956D0 (en) * | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
| CA2902452C (en) | 2013-02-28 | 2018-09-04 | Full Spectrum Laboratories Limited | Chemical engineering processes and apparatus for the synthesis of compounds |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
| US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
| US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
| US9044390B1 (en) | 2014-04-17 | 2015-06-02 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
| US9186386B2 (en) | 2014-04-17 | 2015-11-17 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
| GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| AU2015308136B2 (en) | 2014-08-25 | 2020-07-09 | Teewinot Technologies Limited | Apparatus and methods for the simultaneous production of cannabinoid compounds |
| US10238745B2 (en) | 2015-01-31 | 2019-03-26 | Constance Therapeutics, Inc. | Cannabinoid composition and products including α-tocopherol |
| MX2017009846A (es) | 2015-01-31 | 2018-04-11 | Constance Therapeutics Inc | Metodos para la preparacion de extractos y composiciones de aceite de cannabis. |
| US20180074045A1 (en) * | 2015-05-27 | 2018-03-15 | Cannabics Pharmaceuticals Inc | System and method for high throughput screening of cancer cells |
| EP3380096A4 (de) | 2015-11-24 | 2019-10-23 | Constance Therapeutics, Inc. | Cannabisölzusammensetzungen und verfahren zur herstellung davon |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| KR20210013645A (ko) | 2016-08-03 | 2021-02-04 | 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
| SG11201900501RA (en) | 2016-08-03 | 2019-02-27 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US10058531B1 (en) | 2017-06-01 | 2018-08-28 | Spartak LLC | Dosage delivery film |
| MX2022003189A (es) | 2019-09-16 | 2022-06-08 | Vapor Cartridge Tech Llc | Sistema de administración de fármacos con sustratos apilables. |
| WO2022026613A2 (en) | 2020-07-28 | 2022-02-03 | Impello Biosciences, Inc. | Methods and compositions for altering secondary metabolites in plants |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040039048A1 (en) * | 2000-02-11 | 2004-02-26 | Manuel Guzman Pastor | Therapy with cannabinoid compounds for the treatment of brain tumors |
| ES2164584A1 (es) * | 2000-02-11 | 2002-02-16 | Univ Madrid Complutense | Terapia con cannabinoides para el tratamiento de tumores cerebrales. |
| US6448288B1 (en) * | 2000-05-17 | 2002-09-10 | University Of Massachusetts | Cannabinoid drugs |
| DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| WO2002064109A2 (en) * | 2001-02-14 | 2002-08-22 | Gw Pharma Limited | Mucoadhesive pharmaceutical formulations |
| US6730330B2 (en) * | 2001-02-14 | 2004-05-04 | Gw Pharma Limited | Pharmaceutical formulations |
| GB2377218A (en) * | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
-
2004
- 2004-10-01 GB GB0421900A patent/GB2418612A/en not_active Withdrawn
-
2005
- 2005-09-30 AT AT05788521T patent/ATE408412T1/de not_active IP Right Cessation
- 2005-09-30 JP JP2007534090A patent/JP2008514687A/ja not_active Withdrawn
- 2005-09-30 DE DE602005009852T patent/DE602005009852D1/de active Active
- 2005-09-30 WO PCT/GB2005/003793 patent/WO2006037981A1/en active IP Right Grant
- 2005-09-30 US US11/664,352 patent/US20080262099A1/en not_active Abandoned
- 2005-09-30 CA CA2582289A patent/CA2582289C/en active Active
- 2005-09-30 EP EP05788521A patent/EP1802274B1/de active Active
- 2005-09-30 ES ES05788521T patent/ES2313414T3/es active Active
- 2005-09-30 DK DK05788521T patent/DK1802274T3/da active
-
2012
- 2012-02-06 JP JP2012022885A patent/JP2012131803A/ja active Pending
- 2012-04-05 US US13/440,224 patent/US20120225136A1/en not_active Abandoned
-
2014
- 2014-01-21 JP JP2014008548A patent/JP2014094960A/ja active Pending
- 2014-10-22 JP JP2014215666A patent/JP6280489B2/ja active Active
-
2016
- 2016-09-26 JP JP2016187256A patent/JP2017031190A/ja active Pending
-
2018
- 2018-09-26 US US16/143,094 patent/US20190255011A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014094960A (ja) | 2014-05-22 |
| JP2017031190A (ja) | 2017-02-09 |
| DE602005009852D1 (de) | 2008-10-30 |
| CA2582289C (en) | 2014-10-14 |
| ES2313414T3 (es) | 2009-03-01 |
| EP1802274A1 (de) | 2007-07-04 |
| WO2006037981A1 (en) | 2006-04-13 |
| JP2015038137A (ja) | 2015-02-26 |
| JP2008514687A (ja) | 2008-05-08 |
| JP2012131803A (ja) | 2012-07-12 |
| GB2418612A (en) | 2006-04-05 |
| GB0421900D0 (en) | 2004-11-03 |
| US20080262099A1 (en) | 2008-10-23 |
| US20190255011A1 (en) | 2019-08-22 |
| EP1802274B1 (de) | 2008-09-17 |
| JP6280489B2 (ja) | 2018-02-14 |
| DK1802274T3 (da) | 2009-02-02 |
| WO2006037981A8 (en) | 2006-06-01 |
| US20120225136A1 (en) | 2012-09-06 |
| CA2582289A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
| NL301145I2 (nl) | Tirbanibulin | |
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| GT200800202A (es) | Quinazolinas para la inhibicion de pdk1 | |
| WO2006124892A3 (en) | Modulators of alpha-synuclein toxicity | |
| CY1109551T1 (el) | Πρωτεασωμικοι αναστολεις και μεθοδοι χρησιμοποιησης αυτων | |
| CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| EA201201464A1 (ru) | Новая комбинированная терапия для лечения онкологических и фиброзных заболеваний | |
| BR112015002357A2 (pt) | compostos e composições ativadores de enzimas | |
| TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
| ATE410155T1 (de) | Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung | |
| ATE399175T1 (de) | Hemmstoffe der urokinase, ihre herstellung und verwendung | |
| DE502005005652D1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
| ATE410235T1 (de) | Behandlung von ballastwasser | |
| ATE482218T1 (de) | Inhibitoren von mitotischem kinesin | |
| EA200601471A1 (ru) | Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты) | |
| MX2009011388A (es) | Inhibidores de polimerasa y su uso para el tratamiento de tumores. | |
| ATE445408T1 (de) | Verwendung von prolactin in der prophylaktischen krebstherapie | |
| TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
| ATE358495T1 (de) | Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea | |
| BRPI0407681A (pt) | sulfamatos de d-homoestra-1,3,5(10)-trien-3-ila 2-substituìdos ativos antitumorais | |
| ATE508750T1 (de) | Derivate von vitamin d und ihre verwendung in der therapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| REN | Ceased due to non-payment of the annual fee |